Current treatment protocols for thyroid cancer primarily rely on surgery, radioactive iodine therapy, and thyroid hormone suppression, with targeted therapies considered for patients with progressive or iodine-refractory disease Kaplan–Meier survival analysis indicated that lower expression of BRAF and PIK3 CA is associated with poorer overall survival, while other genes did not show significant differences. Here, PIK3CG is linked to thyroid cancer.